ZBiotics makes genetically engineered probiotics.
Company is active
Event Year: 2017
Company is active
Event Year: 2017
ZBiotics, established in 2016 and based in San Francisco, California, operates as a synthetic biology company. The organization specializes in the bioengineering of probiotic bacteria, targeting applications within the nutraceutical sector and beyond. In 2019, ZBiotics introduced the first commercially available genetically engineered probiotic, designed to metabolize a toxic compound produced during alcohol consumption. Currently, the company is focused on expanding its portfolio with a range of engineered probiotics aimed at addressing various consumer health needs.
ZBiotics, established in 2016 and based in San Francisco, California, operates as a synthetic biology company. The organization specializes in the bioengineering of probiotic bacteria, targeting applications within the nutraceutical sector and beyond. In 2019, ZBiotics introduced the first commercially available genetically engineered probiotic, designed to metabolize a toxic compound produced during alcohol consumption. Currently, the company is focused on expanding its portfolio with a range of engineered probiotics aimed at addressing various consumer health needs.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Healthcare
Healthcare
Healthcare -> Consumer Health and Wellness
Healthcare -> Consumer Health and Wellness
Team size: 22
Hiring: No
Team size: 22
Hiring: No
